Skin rash study for people with IBD on anti-TNF therapy
Part of Digestive system, Infections, Skin clinical trials.
This study looks at the bacteria on skin rashes in people with inflammatory bowel disease (IBD) who are taking anti-TNF medications (a type of biologic). It aims to understand if a common bacteria, Staphylococcus aureus, is linked to these rashes, which could help improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with IBD (like Crohn's disease or ulcerative colitis).
- You are currently taking an anti-TNF medication (such as infliximab, adalimumab, or certolizumab).
- You have skin problems like crusty nose, inflamed scalp, rashes in skin folds (like armpits or groin), or folliculitis (infected hair follicles).
- You are not planning to change your IBD treatment within the next 6 months.
- You are not taking antibiotics (by mouth or on the skin) for at least 1 month before joining.
- You are not pregnant or breastfeeding, and you are not in another drug trial or exclusion period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with active Crohn's disease or ulcerative colitis starting a new type of medication (anti-TNF, ustekinumab, upadacitinib, or vedolizumab), as well as people without IBD having a routine colonoscopy. It aims to collect information to better understand how these treatments work.
This study looks at how chronic inflammatory illnesses progress over time and how treatments affect symptoms and disease markers. You may be invited if you’re receiving care for certain bowel, joint, or skin inflammatory conditions at the hospital.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
This study looks at bacteria in your gut that may produce chemicals linked to ongoing pain in Crohn's disease or ulcerative colitis, even when the disease itself is not very active. Researchers want to understand why some people still have moderate to severe abdominal pain even after their inflammation has calmed down.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
Hear when a new Crohn’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.